GreenWaves Technology has developed a breakthrough new processor specifically designed to power the next generation of AI-powered devices
Belhaven’s needle-free delivery system solves every problem associated with EpiPens, including cost.
A panel discussion on the future of cannabis and innovative financing solutions that are helping drive the industry forward
One of the most efficient and productive ways to mine precious metals is from the 53 megatons of e-Waste produced globally every year
Kineta has developed a new monoclonal antibody designed to reverse immunosuppression and stimulate T Cells.
QSAM has refined an FDA-approved treatment creating a heat seeking missile that has the potential to cure metastatic bone cancer
Gain Therapeutics has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research
Silence Therapeutics is developing a targeted treatment for the 132 million people at risk of heart disease thanks to high Lp(a) levels
bit.bio is unlocking the therapeutic potential of human cells based on a new paradigm – cell reprogramming
Lumeda is a clinical-stage medical technology company focused on improving treatment outcomes for patients with difficult-to-treat cancers.
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office